An up-to-date evaluation of alogliptin benzoate for the treatment of type 2 diabetes-Reference-Cited by-同舟云学术

An up-to-date evaluation of alogliptin benzoate for the treatment of type 2 diabetes

Published:2019-07-23 Issue:14 Volume:20 Page:1679-1687
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Hu Jingbo¹,Yang Chunlin²,Wang Hongbo²,Li Jing²,Tan Xueying³,Wang Jinhui¹,Zhang Bin⁴,Zhao Yufen¹

Affiliation:

1. Institute of Drug Discovery Technology, Ningbo University, Ningbo, China

2. Department of pharmacy, Ningbo University affiliated Yangming Hospital, Yuyao, China

3. College of pharmacy, Zhejiang Pharmaceutical College, Ningbo, China

4. Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, College of Food and Pharmaceutical Sciences, Ningbo University, Ningbo, China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1645124

Reference73 articles.

1. In This Issue of Diabetes Care

2. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

3. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

4. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing the understanding of diabetic encephalopathy through unravelling pathogenesis and exploring future treatment perspectives;Ageing Research Reviews;2024-09